IgG Cleaving Enzymes as a Potential Solution to the NAb Challenge
Time: 11:45 am
day: Day 2 CLINICAL AM
Details:
- An overview of IgG cleaving enzymes: their MOA and translatability for use in conjunction with gene therapies
- Discussing clinical data from non-gene therapy indications
- Considerations for treatment timing and dosing of gene therapy post-administration of enzyme
